Latest Opioid antagonist Stories
Lightlake invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view the presentation. NEW YORK, March 9, 2015 /PRNewswire/ -- Lightlake
LA JOLLA, Calif., Oct.
- Henrico County Sheriff's Office to Receive First Donation - RICHMOND, Va., Oct.
A comparatively new form of a medication for alcohol and opioid dependence that’s injected once a month instead of taken orally once a day appears to be significantly more effective than some other medications – because more patients actually continue the prescribed regimen.
RICHMOND, Va., April 7, 2014 /PRNewswire/ -- Kaleo (formerly Intelliject) today announced that it has entered into a $150 million debt facility with PDL BioPharma (NASDAQ: PDLI) to enable kaleo to
First presentation of detailed BUNAVAIL clinical data scheduled for April 11 and 13, 2014 RALEIGH, N.C., Jan. 30, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc.
Scientists have discovered how the element sodium influences the signaling of a major class of brain cell receptors, known as opioid receptors.
- Growing in low tufty patches.